1. Lumoxiti is an injection for the treatment of adult patients with relapse or refractory hairy cell leukemia, a rare slow-growing cancer in the blood.
2. Cassipa is a buprenorphine and naloxone sublingual film for the treatment of opioid dependence. The FDA approval provides a new dosage strength of the film.
3. Amneal Pharmaceuticals received approval for its generic version of chlorpromazine hydrochloride tablets to treat psychotic disorders or prevent and treat nausea and vomiting.
More articles on supply chain:
AT&T, Merck pilot drones to deliver medical supplies to Puerto Rico
FDA designates bloodless AI test a ‘breakthrough device’
AHRMM names Dee Donatelli chair-elect, announces new board members
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
